![News related image](/img/article-image-placeholder.webp)
![News related image](/img/article-image-placeholder.webp)
GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study
A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.
GLP-1 Drugs Show Significant Health Benefits and Risks in Large-Scale Study
A study of over two million veterans found that GLP-1 drugs, such as Ozempic, significantly reduce risks of neurocognitive disorders, addiction, and self-harm, but also increase the risk of pancreatic and kidney problems.
Progress
52% Bias Score
![News related image](/img/article-image-placeholder.webp)
![News related image](/img/article-image-placeholder.webp)
Trump's AI Agenda: Risks and Uncertainties
Analysis of the potential impact of a second Trump presidency on AI regulation, highlighting concerns about discrimination, disinformation, and existential risks.
Trump's AI Agenda: Risks and Uncertainties
Analysis of the potential impact of a second Trump presidency on AI regulation, highlighting concerns about discrimination, disinformation, and existential risks.
Progress
40% Bias Score
![News related image](/img/article-image-placeholder.webp)
![News related image](/img/article-image-placeholder.webp)
EU Economy to Grow in 2024: Commission
The European Commission forecasts economic growth for the EU in 2024 and 2026, driven by low unemployment but facing risks from protectionism and the war in Ukraine.
EU Economy to Grow in 2024: Commission
The European Commission forecasts economic growth for the EU in 2024 and 2026, driven by low unemployment but facing risks from protectionism and the war in Ukraine.
Progress
0% Bias Score
![News related image](/img/article-image-placeholder.webp)
![News related image](/img/article-image-placeholder.webp)
Dermal Fillers: The Rise, Risks, and Regulation Debate
This article explores the growing trend of dermal fillers, the subsequent rise in hyaluronidase use for dissolving them, and the serious risks and lack of regulation in the UK's aesthetics industry.
Dermal Fillers: The Rise, Risks, and Regulation Debate
This article explores the growing trend of dermal fillers, the subsequent rise in hyaluronidase use for dissolving them, and the serious risks and lack of regulation in the UK's aesthetics industry.
Progress
0% Bias Score
![News related image](/img/article-image-placeholder.webp)
Trump's AI Policy: A Risk to Innovation or Safety?
Analysis of the potential impact of Donald Trump's presidency on AI regulation, highlighting concerns about the risks of deregulation and the perspectives of various experts.
![News related image](/img/article-image-placeholder.webp)
Trump's AI Policy: A Risk to Innovation or Safety?
Analysis of the potential impact of Donald Trump's presidency on AI regulation, highlighting concerns about the risks of deregulation and the perspectives of various experts.
Progress
40% Bias Score
![News related image](/img/article-image-placeholder.webp)
Coffee and Health: Benefits and Risks
This article examines recent research on the health effects of coffee consumption, presenting both potential benefits and risks.
![News related image](/img/article-image-placeholder.webp)
Coffee and Health: Benefits and Risks
This article examines recent research on the health effects of coffee consumption, presenting both potential benefits and risks.
Progress
16% Bias Score
![News related image](/img/article-image-placeholder.webp)
Warning Against Rushing German Elections
Germany's Federal Returning Officer warns against rushing early elections due to significant logistical and organizational challenges.
![News related image](/img/article-image-placeholder.webp)
Warning Against Rushing German Elections
Germany's Federal Returning Officer warns against rushing early elections due to significant logistical and organizational challenges.
Progress
0% Bias Score